Please login to the form below

Not currently logged in
Email:
Password:

Pegasus joins Ashfield Healthcare Communications

Acquired by UDG Healthcare in “strategically important” £16.8m deal
Pegasus joins Ashfield Healthcare Communications

From left: Simon Hackett, Lisa Bradley, Viv Adshead and David Moore

UK healthcare consultancy Pegasus has been bought by UDG Healthcare in a deal valued at up to £16.8m.

Pegasus becomes part of Ashfield Healthcare Communications, a subsidiary of UDG Healthcare's Ashfield Commercial and Medical Services Division, and will be under the leadership of its director David Moore.

Moore said that the acquisition of the healthcare consultancy is “strategically important” for the outsourced services provider.

“It strengthens our existing communications offering and broadens our capabilities in patient and consumer communications programmes, as well as corporate reputation and crisis management for our growing client base,” he added.

Pegasus is one of the UK's largest consumer healthcare-focused PR firms, with a team of 100 employees based in Brighton. Current clients include Daiichi Sankyo, Denplan, DuPont, Lloyds Pharmacy and Novo Nordisk.

Deputy managing director Simon Hackett becomes managing director, while Pegasus' founder Lisa Bradley will become the agency's chairman, taking over from Tim Adams who is departing.

Bradley commented: “Joining Ashfield will increase the breadth and depth of services we offer to our clients and will provide staff with the opportunity to acquire new skills.

“We know they are the right cultural fit for our agency and they share our passion for delivering innovative campaigns across healthcare.”

Article by
Rebecca Clifford

24th May 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics